Text Size Normal Text Sizing Button Medium Text Sizing Button Large Text Sizing Button Text Contrast Normal Contrast Button Reverse Contrast Button Switch to Spanish Language Press Room Contact Us Sitemap Sign In Register
Link to Homepage About BrightFocus
BrightFocus
Donate Now Get Involved  
Alzheimer's Disease Research Macular Degeneration Research National Glaucoma Research


Sign up for Email Notifications
If you would like to be notified when funding or meeting opportunities are announced please click on the link below.

Sign up for new announcements.

This email list is not sold or distributed, and serves only as an annual reminder of the availability of research support through the BrightFocus Foundation (www.brightfocus.org). Please follow instructions on the notification emails for removal requests.

 
 
BrightFocus Research Grants Funding
Grant Funding for Alzheimer's Research
Grant Funding for Macular Degeneration Research
Grant Funding for Glaucoma Research
 

 

Alzheimer's Disease Research
Completed Award

Marco Prado, D. Sc.

Univesidade federal de Minas
Minas Gerais, Brazil

Title: Brain supression of acetylcholine release
Non-Technical Title:

Duration: April 1, 2004 - March 31, 2006
Award Type: Standard
Award Amount: $100,000

Details:


Early cognitive symptoms of Alzheimer’s disease can be improved by drugs that slow the breakdown of an important brain messenger called acetylcholine. Researchers have known that neurons that secrete acetylcholine are vulnerable in Alzheimer’s disease, but so far, they have been unable to understand specifically how a lack of acetylcholine influences behavior. However, recent advances in scientific methodologies make it possible to generate mouse models that have specific mutations. Dr. Prado has hypothesized that these methodologies can now be used to selectively impair or decrease acetylcholine secretion in certain brain regions of the mouse. Certain behaviors can now be studied in these mice and their performance correlated with the levels of acetylcholine secretion in different brain regions. This research will provide fundamental knowledge on how a deficit of acetylcholine contributes to some of the symptoms associated with Alzheimer’s disease.

Publications:

Prado VF, Martins- Silva C, de Castro BM, Lima RF, Barros DM, Amaral E, Ramsey AJ, Sotnikova TD, Ramirez MR, Kim HG, Rossato JI, Koenen J, Quan H, Cota VR, Moraes MF, Gomez MV, Guatimosim C, Wetsel WC, Kushmerick C, Pereira GS, Gainetdinov RR, Izquierdo I, Caron MG, Prado MAM (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51: 601-612. PubMed Icon Google Scholar Icon

Ribeiro FM, Black SAG, Prado VF, Rylett RJ, Ferguson ssG, Prado MAM (2006) The ins and outs of the high affinity choline transporter CHT1. Journal of Neurochemistry 97: 1-12. PubMed Icon Google Scholar Icon

Ribeiro FM, Ferreira LT, Marion S, Fontes S, Gomez MV, Ferguson ssG, Prado MAM, Prado VF. Sec14-like protein 1 interacts with cholinergic transporters. Neurochemistry International 50: 356-364. PubMed Icon Google Scholar Icon

Guidine PA, Rezende GH, Queiroz CM, Mello LE, Prado VF, Prado MAM, Pereira GS, Moraes MF (2008) Vesicular acetylcholine transporter knock-down mice are more susceptible to pilocarpine induced status epilepticus. Neuroscience Letters 436: 201-420. PubMed Icon Google Scholar Icon

de Castro, B.M.; Pereira, G.S.; Magalha~es, V.; Rossato, J.I.; de Jaeger, X.; Martins-Silva, C.; Leles, B.; Lima, P.; Gomez, M.V.; Gainetdinov, R.R.; Caron, M.G.; Izquierdo, I.; Cammarota, M.; Prado, V.F.; Prado, M.A.M. (2008) Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes, Brain and Behavior, 2009 Feb;8(1):23-35. Epub 2008 Sep 6. PubMed Icon Google Scholar Icon